Nivolumab ELISA (mAb-based)

 

Enzyme immunoassay for the specific and quantitative determination of free Nivolumab (Opdivo®) in serum and plasma.

The solid phase (MTP) is coated by a highly specific monoclonal antibody directed against Nivolumab. Therefore any cross reactivity to the other therapeutical monoclonal antibodies is excluded.

Reference: IG-AB113

Barcode: 8699316552604

Legal Status: CE-Mark

Intended Use: This kit has been developed for the measurement of drug levels in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.

Assay Design:

IG-AB113

Related Documents


Quality Control Certificates

Opdivo® is a trademark of Bristol-Myers Squibb Company.

The Kit at a glance:

IG-AB113

Required Volume (µL) 10
Incubation Time (min) 100
Sample Serum or Plasma
Package Size 96 Tests
Standard Range (ng/mL, 10x) 0-6000
Detection Limit (ng/mL) 15
Spike Recovery (%) >95
Shelf Life (years) 2

Standard Curve:

IG-AB113